Clinical Trial Update: Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study [Phase 4]

View source ↗

Summary

Phase 4 RECOVER trial update describing changes in immunologic parameters after adding fostemsavir to virologically suppressed immunologic non-responders with H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Rukobia (fostemsavir)

Snippet

Sponsor: Orlando Immunology Center | Conditions: HIV-1-infection | Phase 4 | Status: ACTIVE_NOT_RECRUITING